Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Cepheid  (Stock symbol: CPHD ) Acquired by Danaher (2016 $ 4,000,000,000 )

904 Carribean Drive
Sunnyvale, CA 94089
Website Company Summary Management Team

Outside board: (May no longer be on the board) Thomas L. Gutshall (Cepheid Former CEO) Kurt Petersen (NovaSensor VP of Technology) Thomas D. Brown (Abbott Laboratories Division SVP Operations);  Gerald Casilli (Ikos Systems CEO) Robert Easton (Easton Associates) Cristina H. Kepner (Invemed Associates) Dean O. Morton (HP Executive VP);  Mitchell Mroz (Northrup Grumman);  Hollings C. Renton (Onyx Pharma)
Advisory board: Tony Godfrey (University of Pittsburgh Asst. Professor)
Former outside board: Ernest Mario (ALZA Pharmaceuticals)

Business description: Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.
Customers include: Northrop Grumman;  U.S. Postal Service
Partners include: BioMerieux

Rounds: 3
Recent Fundings: Aug 2002
Capital raised: 21.3M
Ownership: Acquired by Danaher (2016 $ 4,000,000,000 ) Ipo Filing
Stock Symbol: CPHD
VCs include: Advanced Technology Ventures;  InveMed Associates
Corporate investors: Apple

Last Tweets


Last Mentions

Record updated: Aug 2021
Sector: Biotech
Year Founded: 1996
Headcount: 1601-2000 as of Feb 2019
Rounds: 3
Recent Fundings: Aug 2002
Capital Raised: 21.3M
Ownership: Acquired by Danaher (2016 $ 4,000,000,000 ) Ipo Filing
Stock Symbol: CPHD